News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
538,342 Results
Type
Article (14689)
Company Profile (152)
Press Release (523500)
Multimedia
Podcasts (6)
Webinars (6)
Section
Business (181052)
Career Advice (481)
Deals (27537)
Drug Delivery (19)
Drug Development (58868)
Employer Resources (25)
FDA (11155)
Job Trends (9832)
News (260677)
Policy (20962)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1117)
Academic (1)
Accelerated approval (28)
ADA (19)
Adcomms (2)
Allergies (111)
Alliances (37877)
ALS (117)
Alzheimer's disease (1149)
Antibody-drug conjugate (ADC) (394)
Approvals (11856)
Artificial intelligence (408)
ASCO (207)
Autoimmune disease (252)
Automation (53)
Bankruptcy (276)
Best Places to Work (7741)
BIO (39)
Biologics (2)
BIOSECURE Act (2)
Biosimilars (119)
BioSpace Insights (28)
Biotechnology (98)
Bladder cancer (166)
Brain cancer (36)
Breast cancer (593)
Cancer (4532)
Cardiovascular disease (249)
Career advice (412)
Career pathing (4)
CAR-T (247)
CDC (7)
CDMO (30)
Celiac Disease (2)
Cell therapy (636)
Cervical cancer (42)
Clinical research (52500)
Collaboration (1554)
Commercialization (4)
Company closure (2)
Compensation (1495)
Complete response letters (36)
COVID-19 (1430)
CRISPR (75)
C-suite (855)
Cystic fibrosis (97)
Data (6401)
Denatured (5)
Depression (104)
Dermatology (67)
Diabetes (382)
Diagnostics (5889)
Digital health (41)
Diversity (2)
Diversity, equity & inclusion (6)
Drug discovery (214)
Drug pricing (11)
Drug shortages (5)
Duchenne muscular dystrophy (179)
Earnings (76657)
Editorial (1)
Employer branding (5)
Employer resources (24)
Events (93586)
Executive appointments (789)
FDA (14145)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (26)
Funding (1104)
Gene editing (143)
Generative AI (15)
Gene therapy (395)
GLP-1 (396)
Government (1805)
Grass and pollen (3)
Guidances (303)
Healthcare (10797)
Hematology (116)
HIV (62)
Huntington's disease (22)
IgA nephropathy (69)
Immunology and inflammation (121)
Immuno-oncology (73)
Indications (179)
Infectious disease (1683)
Inflammatory bowel disease (136)
Inflation Reduction Act (4)
Influenza (115)
Intellectual property (273)
Interviews (66)
IPO (13014)
IRA (3)
Job creations (2462)
Job search strategy (391)
JPM (8)
Kidney cancer (18)
Labor market (5)
Layoffs (106)
Leadership (3)
Legal (5569)
Licensing (13)
Liver cancer (54)
Longevity (22)
Lung cancer (593)
Lymphoma (323)
Machine learning (35)
Management (7)
Manufacturing (680)
Marketing (8)
MASH (123)
Medical device (9439)
Medtech (9591)
Mergers & acquisitions (15633)
Metabolic disorders (771)
mRNA (106)
Multiple sclerosis (114)
NASH (5)
Neurodegenerative disease (254)
Neuropsychiatric disorders (42)
Neuroscience (2089)
NextGen: Class of 2026 (3648)
Non-profit (1359)
Now hiring (17)
Obesity (241)
Opinion (44)
Ovarian cancer (186)
Pain (179)
Pancreatic cancer (234)
Parkinson's disease (235)
Partnered (22)
Patents (516)
Patient recruitment (570)
Peanut (39)
People (45087)
Pharmaceutical (34)
Pharmacy benefit managers (8)
Phase 1 (17250)
Phase 2 (23272)
Phase 3 (16002)
Pipeline (8264)
Policy (26)
Postmarket research (1777)
Preclinical (7419)
Press Release (45)
Prostate cancer (281)
Psychedelics (8)
Radiopharmaceuticals (253)
Rare diseases (636)
Real estate (4156)
Recruiting (9)
Regulatory (17257)
Reports (22)
Research institute (1207)
Resumes & cover letters (61)
Rett syndrome (43)
RNA editing (6)
RSV (54)
Schizophrenia (105)
Series A (191)
Series B (133)
Service/supplier (5)
Sickle cell disease (72)
Spinal muscular atrophy (96)
Sponsored (12)
Startups (2390)
State (1)
Stomach cancer (4)
Supply chain (64)
Tariffs (1)
The Weekly (1)
Vaccines (570)
Venture capital (19)
Weight loss (87)
Women's health (91)
Worklife (1)
Date
Today (112)
Last 7 days (413)
Last 30 days (1810)
Last 365 days (21014)
2026 (14128)
2025 (21017)
2024 (25353)
2023 (29361)
2022 (38395)
2021 (41394)
2020 (37999)
2019 (26855)
2018 (20179)
2017 (21710)
2016 (20968)
2015 (27078)
2014 (23987)
2013 (20326)
2012 (22291)
2011 (22597)
2010 (22056)
Location
Africa (334)
Alabama (80)
Alaska (3)
Arizona (327)
Arkansas (11)
Asia (22488)
Australia (3248)
California (12603)
Canada (3350)
China (708)
Colorado (511)
Connecticut (445)
Delaware (251)
Europe (38410)
Florida (1887)
Georgia (398)
Hawaii (3)
Idaho (47)
Illinois (782)
India (62)
Indiana (405)
Iowa (16)
Japan (439)
Kansas (114)
Kentucky (42)
Louisiana (34)
Maine (35)
Maryland (1352)
Massachusetts (8441)
Michigan (322)
Minnesota (612)
Mississippi (4)
Missouri (138)
Montana (27)
Nebraska (12)
Nevada (129)
New Hampshire (69)
New Jersey (2946)
New Mexico (20)
New York (2992)
North Carolina (1445)
North Dakota (4)
Northern California (6288)
Ohio (353)
Oklahoma (15)
Oregon (19)
Pennsylvania (2418)
Puerto Rico (22)
Rhode Island (36)
South America (547)
South Carolina (79)
South Dakota (1)
Southern California (5253)
Tennessee (144)
Texas (2083)
United States (41956)
Utah (385)
Vermont (1)
Virginia (173)
Washington D.C. (42)
Washington State (1014)
West Virginia (1)
Wisconsin (98)
Wyoming (2)
538,342 Results for "antigen laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ainnocence Shows AINN-P1 Protein Foundation Model Improves Antibody-Antigen Affinity Ranking by 28% - From Sequence Alone
Ainnocence’s foundation model trained from scratch, requiring no structure, no multiple sequence alignment, no fine-tuning, training in hours rather than weeks.
August 27, 2026
·
1 min read
Cancer
Pfizer Searches for Novel Tumor-Selective Antigens With $865M+ Cartography Pact
Cartography will hunt for novel tumor antigens, which Pfizer can opt into and advance into clinical development.
January 7, 2026
·
2 min read
·
Tristan Manalac
Press Releases
NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression
July 10, 2026
·
6 min read
Press Releases
Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors
July 16, 2026
·
4 min read
Press Releases
Matica Bio and VaxDome Partner to Develop Antigen-Agnostic Antiviral-Vaccine Hybrids with Influenza as One of the Disease Models
July 6, 2026
·
3 min read
Press Releases
Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity Assay
June 19, 2026
·
1 min read
Press Releases
Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products
April 15, 2026
·
7 min read
Press Releases
Charles River Laboratories Announces Second-Quarter 2026 Results
August 5, 2026
·
19 min read
Press Releases
Laboratory Modernization Strengthens QPS Holdings, LLC’s Long-Term Commitment to Elemental Bioanalysis
August 31, 2026
·
3 min read
Press Releases
Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories
August 11, 2026
·
4 min read
1 of 53,835
Next
